Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars
Launched by GIHAN M ABUELNIEL ,PHD · Feb 8, 2019
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Diagnosis:
1. Full history data will be collected, including personal, medical and previous dental data
2. Clinical examination using mirror and probe to assess the inclusion criteria.
3. Radiographic examination using preoperative digital periapical radiograph to assess the inclusion criteria.
4. Preoperative photograph will be taken.
Operative procedure:
Experimental group:
1. Injection of local anesthesia and rubber dam isolation.
2. caries and roof of the pulp chamber will be removed by a fissure diamond bur (Diatech, Heerbrug, Switzerland) and high-speed handpiece with coolant.
3. ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bilaterally Symptomatic ⁄ asymptomatic vital immature mandibular first permanent molars (with clinical carious exposure of the pulp and presence of bleeding upon exposure)
- • Patients with an age range from 7-8 years.
- • Absence of sinus tract, soft tissue swelling.
- Exclusion Criteria:
- • • Molars were excluded if non-restorable.
- • excessive mobility (more than 1 mm horizontally).
- • Radiographic evidence of peri- and ⁄or inter-radicular lesions, internal⁄ external root resorption, pulp⁄ canal calcifications.
About Gihan M Abuelniel ,Phd
Dr. Gihan M. Abuelniel, PhD, is a distinguished clinical trial sponsor with a robust background in biomedical research and a commitment to advancing medical science through innovative clinical studies. With expertise in trial design, regulatory compliance, and data analysis, Dr. Abuelniel leads initiatives that prioritize patient safety and efficacy in therapeutic interventions. Her collaborative approach fosters partnerships with healthcare professionals and research institutions, ensuring that each study is conducted with the highest ethical standards and scientific rigor. Driven by a passion for improving patient outcomes, Dr. Abuelniel is dedicated to translating research findings into tangible healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Gihan M Abuelniel, PhD
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials